Literature DB >> 16382252

Beyond Ortner's syndrome--unusual pulmonary complications of the giant left atrium.

G C Phua1, P C T Eng, S L Lim, Y L Chua.   

Abstract

INTRODUCTION: The giant left atrium (GLA) is a complication of severe mitral valve disease and causes morbidity by compressing adjacent intra-thoracic structures. CLINICAL PICTURE: We report 2 cases of unusual pulmonary complications of the GLA. Case 1 developed recurrent collapse of the left lung due to left main bronchus compression. Case 2 was diagnosed with right middle lobe compression and collapse. TREATMENT AND OUTCOME: Case 1 was successfully treated by mitral valve replacement and left atrial reduction surgery. Case 2 was treated conservatively.
CONCLUSION: Pulmonary atelectasis may occur in patients with GLA due to bronchopulmonary compression. Surgical management with valve replacement and atrial reduction may be necessary to relieve airway compression.

Entities:  

Mesh:

Year:  2005        PMID: 16382252

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  6 in total

1.  A rare cardiac cause of hoarseness of voice.

Authors:  Ismail I Berekat; Abdulrahman Azzu
Journal:  Libyan J Med       Date:  2010-01-07       Impact factor: 1.657

2.  A "non-rheumatic" giant left atrium.

Authors:  Imran Ahmed; Achyut Sarkar; Arindam Pande; Chanchal Kundu
Journal:  Ann Pediatr Cardiol       Date:  2015 Jan-Apr

3.  An Audaciously Aneurysmal Atrium.

Authors:  Cameron L McBride; Steven Assalita; Alexander Bolanos; Ihab Hamzeh
Journal:  CASE (Phila)       Date:  2018-02-16

4.  Silent giant left atrium: A case report.

Authors:  Shweta Vohra; Akshyaya Pradhan; Vikash Jaiswal; Prachi Sharma; Nishan Babu Pokhrel; David Song
Journal:  Clin Case Rep       Date:  2022-02-01

5.  Giant left atrium: a review.

Authors:  Ahmed El Maghraby; Rachel Hajar
Journal:  Heart Views       Date:  2012-04

6.  Rheumatic mitral stenosis in children: more accelerated course in sub-Saharan patients.

Authors:  Henok Tadele; Wubegzier Mekonnen; Endale Tefera
Journal:  BMC Cardiovasc Disord       Date:  2013-11-01       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.